Denmark· DK-28106743122
TECVAYLI
A teclistamab product containing teclistamab, registered in Denmark by Janssen-Cilag International NV. The same ATC class is registered in 14 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Teclistamab is registered in 14 of 19 countries.
Countries holding a registration under ATC L01FX24 (teclistamab), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Teclistamab · ATC L01FX24
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Teclistamab
- Manufacturer
- Janssen-Cilag International NV
- Country
- Denmark (DK)
- ATC code
- L01FX24
- ATC class
- Teclistamab
- Defined daily dose
- 15 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106743122
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L01FX24
Teclistamab, as other registers publish it.
- NorwayTecvayliJanssen-Cilag International N.V.
- NorwayTecvayliJanssen-Cilag International N.V.
- IcelandTecvayliJanssen-Cilag International NV*
- IcelandTecvayliJanssen-Cilag International NV*
- FinlandTECVAYLIAbacus Medicine A/S
- FinlandTECVAYLIJanssen-Cilag International NV
- PolandTECVAYLIJanssen-Cilag International N.V.
- FinlandTECVAYLIAbacus Medicine A/S
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ed07565a-ce68-4ef5-a101-a243e9ec22a3 GET /v1/drugs/ed07565a-ce68-4ef5-a101-a243e9ec22a3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning",
"source": "dkma",
"strength": "90 mg/ml",
"auth_role": "MOD",
"dk_drugid": "28106743122",
"substance": "Teclistamab",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "44796"
}See everything about teclistamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.